These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 27153991)

  • 1. Development of therapeutic antibodies to G protein-coupled receptors and ion channels: Opportunities, challenges and their therapeutic potential in respiratory diseases.
    Douthwaite JA; Finch DK; Mustelin T; Wilkinson TC
    Pharmacol Ther; 2017 Jan; 169():113-123. PubMed ID: 27153991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of functional monoclonal antibodies targeting G-protein-coupled receptors and ion channels.
    Wilkinson TC
    Biochem Soc Trans; 2016 Jun; 44(3):831-7. PubMed ID: 27284048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generating therapeutic monoclonal antibodies to complex multi-spanning membrane targets: Overcoming the antigen challenge and enabling discovery strategies.
    Dodd R; Schofield DJ; Wilkinson T; Britton ZT
    Methods; 2020 Aug; 180():111-126. PubMed ID: 32422249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of functional antibodies targeting ion channels.
    Wilkinson TC; Gardener MJ; Williams WA
    J Biomol Screen; 2015 Apr; 20(4):454-67. PubMed ID: 25473082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Monoclonal Antibodies to Complex Membrane Protein Targets: Antigen Generation and Antibody Discovery Strategies.
    Dodd RB; Wilkinson T; Schofield DJ
    BioDrugs; 2018 Aug; 32(4):339-355. PubMed ID: 29934752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics.
    Mujić-Delić A; de Wit RH; Verkaar F; Smit MJ
    Trends Pharmacol Sci; 2014 May; 35(5):247-55. PubMed ID: 24690241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for therapeutic antibodies directed at G-protein-coupled receptors.
    Hutchings CJ; Koglin M; Olson WC; Marshall FH
    Nat Rev Drug Discov; 2017 Sep; 16(9):787-810. PubMed ID: 28706220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening Strategies for the Discovery of Ion Channel Monoclonal Antibodies.
    Colley CS; England E; Linley JE; Wilkinson TCI
    Curr Protoc Pharmacol; 2018 Sep; 82(1):e44. PubMed ID: 30168908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mini-review: antibody therapeutics targeting G protein-coupled receptors and ion channels.
    Hutchings CJ
    Antib Ther; 2020 Dec; 3(4):257-264. PubMed ID: 33912796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic antibodies directed at G protein-coupled receptors.
    Hutchings CJ; Koglin M; Marshall FH
    MAbs; 2010; 2(6):594-606. PubMed ID: 20864805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen Design for Successful Isolation of Highly Challenging Therapeutic Anti-GPCR Antibodies.
    Ju MS; Jung ST
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugability of extracellular targets: discovery of small molecule drugs targeting allosteric, functional, and subunit-selective sites on GPCRs and ion channels.
    Grigoriadis DE; Hoare SR; Lechner SM; Slee DH; Williams JA
    Neuropsychopharmacology; 2009 Jan; 34(1):106-25. PubMed ID: 18800070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3.
    Bobkov V; Arimont M; Zarca A; De Groof TWM; van der Woning B; de Haard H; Smit MJ
    Mol Pharmacol; 2019 Dec; 96(6):753-764. PubMed ID: 31481460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts.
    Lappano R; Maggiolini M
    Drugs; 2017 Jun; 77(9):951-965. PubMed ID: 28401445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cell-cell interaction format for selection of high-affinity antibodies to membrane proteins.
    Yang Z; Wan Y; Tao P; Qiang M; Dong X; Lin CW; Yang G; Zheng T; Lerner RA
    Proc Natl Acad Sci U S A; 2019 Jul; 116(30):14971-14978. PubMed ID: 31285332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Membrane protein production and formulation for drug discovery.
    Gulezian E; Crivello C; Bednenko J; Zafra C; Zhang Y; Colussi P; Hussain S
    Trends Pharmacol Sci; 2021 Aug; 42(8):657-674. PubMed ID: 34270922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential use of G protein-coupled receptor-blocking monoclonal antibodies as therapeutic agents for cancers.
    Herr DR
    Int Rev Cell Mol Biol; 2012; 297():45-81. PubMed ID: 22608557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of antibody-based therapeutics targeting G protein-coupled receptors: an update.
    Hutchings CJ
    Expert Opin Biol Ther; 2020 Aug; 20(8):925-935. PubMed ID: 32264722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 - April 1, 2016, Tours, France.
    Desoubeaux G; Reichert JM; Sleeman M; Reckamp KL; Ryffel B; Adamczewski JP; Sweeney TD; Vanbever R; Diot P; Owen CA; Page C; Lerondel S; Le Pape A; Heuze-Vourc'h N
    MAbs; 2016; 8(6):999-1009. PubMed ID: 27266390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and design of G protein-coupled receptor targeting antibodies.
    Peterson SM; Hutchings CJ; Hu CF; Mathur M; Salameh JW; Axelrod F; Sato AK
    Expert Opin Drug Discov; 2023 Apr; 18(4):417-428. PubMed ID: 36992620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.